0002000684 2026-07-27 2026-07-27 0002000684 1 2026-07-27 2026-07-27 0002000684 2 2026-07-27 2026-07-27 0002000684 3 2026-07-27 2026-07-27 0002000684 4 2026-07-27 2026-07-27 0002000684 5 2026-07-27 2026-07-27 0002000684 6 2026-07-27 2026-07-27 0002000684 7 2026-07-27 2026-07-27 0002000684 8 2026-07-27 2026-07-27 0002000684 9 2026-07-27 2026-07-27 iso4217:USD pure F-1 F-1 EX-FILING FEES 0002000684 Devonian Health Group Inc. N/A N/A F-1 Devonian Health Group Inc. false Equity Common Units, each Common Unit consisting of one Common Share, no par value, and one Warrant to purchase one Common Share true 28244000.00 0.0001381 3900.50 false Equity Common Shares included in the Common Units true 0.0001381 0.00 false Equity Warrants included in the Common Units true 0.0001381 0.00 false Equity Common Shares underlying Warrants included in the Common Units (at an exercise price of 125% of the price of the Common Units) true 35305000.00 0.0001381 4875.62 false Equity Warrants to be issued to the underwriter true 0.0001381 0.00 false Equity Common Shares underlying Warrants issued to the underwriter true 1765250.00 0.0001381 243.78 false Equity Pre-funded Units, each Pre-funded Unit consisting of one Pre-funded Warrant and one Warrant, each to purchase one Common Share true 0.0001381 0.00 false Equity Pre-funded Warrants included in the Common Units true 0.0001381 0.00 false Equity Pre-funded Warrants included in the Common Units true 0.0001381 0.00 65314250.00 9019.90 0.00 0.00 9019.90 1.a. Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) of the Securities Act of 1933. 1.b. Includes common shares and warrants that may be purchased by the underwriter pursuant to its option to purchase additional common shares and warrants to cover over-allotments. 1.c. Pursuant to Rule 416 under the Securities Act, there are also being registered such indeterminate number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or similar transactions. 1.d. We have agreed to issue to ThinkEquity LLC, Underwriter Warrants that are immediately exercisable at an exercise price equal to 125% of the price per common unit issued in the offering, representing up to 5.0% of the common shares included in the common units issued in the offering. Resales of the Underwriter Warrants on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, as amended, are registered hereby. Resales of common shares issuable upon exercise of the Underwriter Warrants are also being similarly registered on a delayed or continuous basis hereby. As estimated solely for the purpose of recalculating the registration fee pursuant to Rule 457(g) under the Securities Act, the proposed maximum aggregate offering price of the Underwriter Warrants is $1,765,250, which is equal to 125% of $1,412,200 (5.0% of $28,244,000). See Underwriting. See Offering Notes 1.a. and 1.c. 2.a. No registration fee required pursuant to Rule 457(g). See Offering Notes 1.a., 1.c, and 2.a. See Offering Notes 1.a., 1.c., and 1.d. Note 4.a. The warrants are exercisable at a price per common share equal to 125% of the common unit offering price. See Offering Note 1.a. See Offering Notes 1.a., 1.c., 1.d., and 4.a. See Offering Note 1.c. 7.a. The proposed maximum aggregate offering price of the common shares will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common shares issued in the offering. See Offering Notes 1.c., 2.a, and 7.a. See Offering Notes 1.c, and 7.a.